Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,670 INR | -0.03% | +0.06% | -0.63% |
Strengths
- The group's high margin levels account for strong profits.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 35.69 times its estimated earnings per share for the ongoing year.
- With an enterprise value anticipated at 4.55 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.63% | 1.27B | - | ||
-5.94% | 266B | A- | ||
-3.51% | 93.75B | C+ | ||
+6.16% | 40.42B | B- | ||
-1.60% | 39.92B | B- | ||
+7.31% | 39.47B | B- | ||
-18.07% | 29.26B | B- | ||
-7.67% | 28.39B | A | ||
+12.84% | 25.04B | A- | ||
-5.93% | 23.52B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ZYDUSWELL Stock
- ZYDUSWELL Stock
- Ratings Zydus Wellness Limited